Endocrine Society elects Santoro as 2026-2027 President

Endocrine Society members elected Nanette Santoro, M.D., of the University of Colorado School of Medicine in Aurora, Colo., as its 2026-2027 President. She will serve as President-Elect for a year beginning in July 2025 before becoming President in June 2026.

Santoro has served as E. Stewart Taylor Chair of Obstetrics & Gynecology at the University of Colorado School of Medicine since 2010. She is a well-recognized practitioner, dedicated mentor and leading researcher on studies of women with premature and age-appropriate menopause.

She has held many roles with the Endocrine Society, including serving as Vice President of Clinical Science, an author on two women’s reproductive health Clinical Practice Guidelines and Chair of the Society’s Scientific Statement on bioidentical hormones. She also won the Society’s 2016 Laureate Award for Outstanding Mentorship.

The Society also selected four other members to join its Board of Directors beginning in July 2025: 

• Cherié Butts, Ph.D., Biogen, Cambridge, Mass.: Butts is medical director of the Therapeutics Development Unit at Biogen. Prior to Biogen, she conducted research on neuroendocrine regulation of immune responses and served as a reviewer of drug/biologics applications at the U.S. Food and Drug Administration (FDA). She is passionate about providing opportunities for individuals from all backgrounds to contribute to biomedical research. She was previously Chair of the Society’s Nominating Committee and a member of its Committee on Diversity & Inclusion.

• Leonor Corsino, M.D., Duke University School of Medicine, Durham, N.C.: Corsino is currently an associate professor in the Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, and associate professor of population health sciences at the Duke University School of Medicine. Her research focuses on diabetes and related conditions, Hispanic/Latino populations, implicit bias and health disparities. Corsino has served on the Endocrine Society’s Clinical Endocrinology Update Committee and its Committee on Diversity & Inclusion.

• Patricia Morris, Ph.D., M.S., The Rockefeller University, New York, N.Y.: Morris is a guest investigator, RNA Molecular Biology, at The Rockefeller University. She serves as a special series editor, One Health, for the Federation of American Societies for Experimental Biology (FASEB) Journal/Wiley. She also is a senior scientist and health policy advisor for Secondcell Bio, a biotech company with a global health focus. She is a member of the Endocrine Society’s Advocacy and Public Outreach Core Committee and was previously a member of its Research Affairs Core Committee and on the editorial board for the Society’s basic science journal, Endocrinology.

• Heather Patisaul, Ph.D., National Institutes of Health (NIH), Environmental Health Sciences (NIEHS), Durham, N.C.: Patisaul is the scientific director of the Division of Translational Toxicology at NIEHS. Her research lab explores the mechanisms by which endocrine-disrupting chemicals (EDCs) alter neuroendocrine pathways in the brain related to sex-specific physiology and behavior. She has held many roles within the Endocrine Society, currently serving as a member of its bisphenol A (BPA) Task Force and as Chair of its Organization for Economic Co-operation and Development (OECD)/Environmental Protection Agency (EPA) Task Force.
  
  

Board members will begin serving their three-year terms following ENDO 2025. The Society’s annual meeting will take place July 12-15, 2025, in San Francisco, Calif.

About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom.